NanoVibronix, Inc. (NASDAQ:NAOV) Short Interest Down 58.0% in January

NanoVibronix, Inc. (NASDAQ:NAOV) was the target of a significant decline in short interest in January. As of January 15th, there was short interest totalling 249,900 shares, a decline of 58.0% from the December 31st total of 594,600 shares. Based on an average daily trading volume, of 1,380,000 shares, the days-to-cover ratio is presently 0.2 days. Approximately 6.7% of the shares of the stock are sold short.

NanoVibronix Stock Down 11.0 %

Shares of NanoVibronix stock traded down $0.07 on Friday, reaching $0.53. The company’s stock had a trading volume of 2,242,400 shares, compared to its average volume of 9,167,701. NanoVibronix has a 52-week low of $0.37 and a 52-week high of $1.52. The company has a market capitalization of $1.97 million, a P/E ratio of -0.43 and a beta of 1.64. The stock has a 50-day moving average price of $0.59 and a 200-day moving average price of $0.61.

About NanoVibronix

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.